Elanco Animal Health vs Jazz Pharmaceuticals
Elanco Animal Health and Jazz Pharmaceuticals are similar in size: $4.71bn and $4.27bn of revenue in their latest fiscal years. Elanco Animal Health grew faster (6.2% against 4.9%). Elanco Animal Health kept more of each dollar of sales as profit: a net margin of -4.9% against -8.3%. Elanco Animal Health carries less debt relative to equity (61.4% against 125.3%).
| Latest fiscal year | Elanco Animal HealthELAN, 2025 | Jazz PharmaceuticalsJAZZ, 2025 |
|---|---|---|
| Revenue | $4.71bn | $4.27bn |
| Revenue growth | 6.2% | 4.9% |
| Net income | −$232m | −$356m |
| Operating margin | — | -10.1% |
| Net margin | -4.9% | -8.3% |
| Return on equity | -3.7% | -8.5% |
| Free cash flow | $284m | $1.30bn |
| Cash | $545m | $1.39bn |
| Total debt | $4.02bn | $5.41bn |
| Debt to equity | 61.4% | 125.3% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | $125m |
| Employees | 9,000 | 700 |
| Market value | $12.04bn | $13.87bn |
| Price vs our value range | Above our value range | Below our value range |
| Moat score | 42 (Weak) | 66 (Moderate) |
| Insider trades, 12 months | 11 buys, 1 sales | 0 buys, 59 sales |